Bicara Therapeutics, Inc. (BCAX)
18.72
-0.17
(-0.90%)
USD |
NASDAQ |
Dec 09, 16:00
18.72
0.00 (0.00%)
After-Hours: 20:00
Bicara Therapeutics Market Cap: 1.026B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 144.02B |
| Oncotelic Therapeutics, Inc. | 41.16M |
| Dogwood Therapeutics, Inc. | 13.78M |
| CEL-SCI Corp. | 20.21M |
| AIM ImmunoTech, Inc. | 1.139M |
Market Cap Related Metrics
| PEG Ratio | -0.1141 |
| Price to Book Value | 2.546 |
| Price | 18.72 |
| Earnings Yield | -11.91% |
| PEGY Ratio | -0.1141 |